Perceptions of young women using SSRI antidepressants - A reclassification of stigma

International Journal of Pharmacy Practice

Volumn 10, Issue 4, 2002, Pages 243-252

  Knudsen, Pia ^a   Hansen, Ebba Holme ^a   Traulsen, Janine M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; DENMARK; DEPRESSION; DOCTOR PATIENT RELATION; DRUG INDICATION; DRUG INFORMATION; DRUG USE; EMOTION; FEMALE; HEALTH CARE QUALITY; HUMAN; INTERVIEW; PATIENT CARE; PATIENT EDUCATION; PERCEPTION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT;

EID: 0036967896     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/096176702776868415     Document Type: Article

References (35)

1. Larsen BO, Hansen EH. The active medicine user. Scand J Prim Health Care 1985;3:55-9.
2. Conrad P. The meaning of medication: Another look at compliance. Soc Sci Med 1985;20:29-37.
3. Almarsdóttir AB, Morgall JM. Technicians or patient advocates? - still a valid question. Pharm World Sci 1999;21:127-31.
4. Hansen EH, Launsø L. Drugs and users - problems and new directions. Health Promot 1988;3:241-8.
5. Hansen EH. How widely do women and men differ in their use of psychotropic drugs? A review of Danish studies. J Soc Admin Pharm 1989;6:165-83.
6. Hansen EH. Sovemedicin og nervemedicin - brug, afhængighed, intervention [Hypnotics and tranquillisers - use, dependency and intervention]. The Danish Medicines Agency. Copenhagen: Schultz; 1997.
7. Graham K, Vidal-Zeballos D. Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of other substances. Soc Sci Med 1998;46:381-95.
8. Cooperstock R, Lennard HL. Some social meanings of tranquilizer use. Sociol Health Ill 1979;1:331-47.
9. Helman CG. 'Tonic', 'fuel' and 'food': social and symbolic aspects of the long-term use of psychotropic drugs. Soc Sci Med 1981;15B:521-33.
10. Gabe J, Thorogood N. Prescribed drug use and the management of everyday life: the experiences of black and white working-class women. Sociol Rev 1986;34:737-72.
11. Karp DA. Taking anti-depressant medications: Resistance, trial commitment, conversion, disenchantment. Qualitat Sociol 1993;16:337-59.
12. Lxgemiddelforbruget i Danmark i 1986-1991 [Drug consumption in Denmark in 1986-1991]. Copenhagen: Danish Drug Statistics.
13. Danish Medicines Agency. Lægemiddelstatistik 1995-1999. [Drug statistics 1995-1999] 2000 (18.09.2000). Available at: http://www.medicinpriser.dk/docushare/dscgi/ds.py/View/Collection-154
14. The Swedish National Board of Health and Welfare. Läkemedel i användning - förändring och tendenser. Kvartalsrapport 2000:1 Artikelnummer: 2000-77-021 [Drug applications - changes and trends. Quarterly report. Article number: 2000-77-021] 2000 (05.01.2001). Available at: www.sos.se/FULLTEXT/0077-012/0077-012.htm
15. Finnish Statistics on Medicine 2000. Helsinki: The Finnish National Agency for Medicines and Social Insurance Institution; 2001.
16. Det norske social - og helsedepartementet. Drug consumption in Norway 1996-2000. Available at: http://www.legemiddelforbruk.nmd.no
17. Medawar C. The antidepressant web. Marketing depression and making medicines work. Int J Risk Safety Med 1997;10:75-126.
18. Goffman E. The insanity of place. In: Davey B, Gray A, Seale C, editors. Health and disease: a reader. Philadelphia: Open University Press; 1995. p72-8.
19. Goffman E. Stigma. Notes on the management of spoiled identity. Harmondsworth: Penguin; 1963.
20. Link BG. Understanding labelling effects in the area of mental disorders: An empirical assessment of the effects of expectations of rejection. Am Sociol Rev 1987;52:96-112.
21. Link BG, Cullen FT, Stuening E, Shrout PE, Dohrenwend BP. A modified labelling theory of mental disorder: An empirical assessment. Am Sociol Rev 1989;54:400-2.
22. Taylor SJ, Bogdan R. Introduction to qualitative research methods. A guidebook and resource. 3rd ed. New York: John Wiley & Sons; 1998.
23. Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New York: Aldine Publishing Co; 1967.
24. Karp DA. Living with depression: Illness and identity turning points. Qualitat Health Res 1994;4:6-30.
25. Wahl OF. Mental health consumers' experience of stigma. Schizophr Bull 1999;25:467-78.
26. Thesen J. Being a psychiatric patient in the community - reclassified as the stigmatized "other". Scand J Public Health 2001;29:248-55.
27. Knudsen P, Hansen EH, Traulsen JM, Eskildsen K. Changes in self-concept while using SSRI antidepressants. Qualitat Health Res 2002;12:932-44.
28. Hansen EH, Helweg-Jørgensen S. Psykofarmakaafhangighed i et brugerperspektiv [Dependency of psychotropic drugs in a user perspective]. Social Kritik 2000;68:34-7.
29. Rogers A, Day JC, Williams B, Randell F, Wood P, Healy D, et al. The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Soc Sci Med 1998;47:1313-23.
30. Byrne P. Psychiatric stigma: Past, passing and to come. J R Soc Med 1997;90:618-21.
31. Helweg-Jørgensen S, Hansen EH. Keeping up appearances. Experiences with benzodiazepine use and dependency. Subst Use Misuse (in press).
32. Schreiber R. (Re)Defining myself: Women's process of recovery from depression. Qualitat Health Res 1996;6:468-491.
33. Chernomas WM. Experiencing depression: women's perspective in recovery. J Psychiatr Ment Health 1997;4:393-400.
34. Schneider JW, Conrad P. In the closet with illness: Epilepsy, stigma potential and information control. Soc Probl 1980;28:32-44.
35. Scambler G, Hopkins A. Being epileptic: Coming to terms with stigma. Sociol Health Ill 1986;8:26-43.